Mike Kelly sold Nu Skin Enterprises Inc (NYSE: NUS)
Mike Kelly (R-PA), a U.S. Representative, has disclosed 1 trade in Nu Skin Enterprises Inc (NUS) since 2014, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Mike Kelly sold $1,000 - $15,000 of Nu Skin Enterprises Inc (NYSE: NUS) on March 5, 2014. Since that trade, NUS is down -89.86% against the S&P 500 up +378.33%, an outperformance of -468.19%.
Data updated
Mike Kelly's NUS trades vs the price
NUS is down -89.86% since Mike Kelly sold on March 5, 2014, versus +378.33% for the S&P 500.
Performance since this trade
All Mike Kelly NUS trades
Mike Kelly & NUS trading FAQ
Is it legal for Mike Kelly to trade Nu Skin Enterprises Inc (NUS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Nu Skin Enterprises Inc (NUS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mike Kelly sell NUS?
Mike Kelly disclosed a sale of $1,000 - $15,000 of Nu Skin Enterprises Inc (NUS) on March 5, 2014, according to public STOCK Act filings.
How has NUS performed since Mike Kelly's trade?
Since Mike Kelly sold NUS on March 5, 2014, the stock is down -89.86%, versus +378.33% for the S&P 500 over the same period, an outperformance of -468.19%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NUS trades?
Quantellect tracks every disclosed congressional trade in Nu Skin Enterprises Inc (NUS) on the Nu Skin Enterprises Inc congressional trading page, which aggregates filings across all members of Congress.
Mike Kelly's NUS tradesAll congressional filings for Nu Skin Enterprises IncMike Kelly's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.